Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Anti-Xa based dosing of enoxaparin in hematopoietic stem cell transplant and adoptive cell therapy patients: A single center experience. Thromb Res 2022 Mar;211:6-9

Date

01/21/2022

Pubmed ID

35051832

DOI

10.1016/j.thromres.2022.01.012

Scopus ID

2-s2.0-85123020405 (requires institutional sign-in at Scopus site)

Author List

Jizzini M, Akhtar OS, Atwood K, Ji W, Pleskow J, Bat T, Balderman S

Author

Othman S. Akhtar MBBS Assistant Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Anticoagulants
Cell- and Tissue-Based Therapy
Enoxaparin
Factor Xa Inhibitors
Hematopoietic Stem Cell Transplantation
Heparin, Low-Molecular-Weight
Humans
Venous Thromboembolism